Login
Home
Charts
Search
Watchlist
Products

Clinitech Laboratory Ltd

CTLLAB·BSE
₹35.100.00%Tue, 1 Sept '26
Industry:Diagnostic Services
Indices:

Clinitech Laboratory Ltd

CTLLAB
BSE
₹35.10
0.00%
|Tue, 1 Sept '26
SOICxStockScans Reports
Industry
Diagnostic Services
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹8Cr
Close
Close Price
₹35.10
Industry
Industry
Diagnostic Services
PE
Price To Earnings
19.08
PS
Price To Sales
0.84
Revenue
Revenue
₹9Cr
Rev Gr TTM
Revenue Growth TTM
15.18%
PAT Gr TTM
PAT Growth TTM
6.36%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
4454
Growth YoY
Revenue Growth YoY%
24.56.0
Expenses
ExpensesCr
4454
Operating Profit
Operating ProfitCr
1010
OPM
OPM%
13.76.710.610.2
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
1011
Tax
TaxCr
0000
PAT
PATCr
0000
Growth YoY
PAT Growth YoY%
36.4-35.3
NPM
NPM%
5.44.15.92.5
EPS
EPS₹
1.00.81.30.5
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
4454
Growth YoY
Revenue Growth YoY%
24.56.0
Expenses
ExpensesCr
4454
Operating Profit
Operating ProfitCr
1010
OPM
OPM%
13.76.710.610.2
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
1011
Tax
TaxCr
0000
PAT
PATCr
0000
Growth YoY
PAT Growth YoY%
36.4-35.3
NPM
NPM%
5.44.15.92.5
EPS
EPS₹
1.00.81.30.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
89
Growth
Revenue Growth%
15.3
Expenses
ExpensesCr
79
Operating Profit
Operating ProfitCr
11
OPM
OPM%
10.110.4
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
01
PBT
PBTCr
11
Tax
TaxCr
00
PAT
PATCr
00
Growth
PAT Growth%
5.1
NPM
NPM%
4.84.4
EPS
EPS₹
1.91.8
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
89
Growth
Revenue Growth%
15.3
Expenses
ExpensesCr
79
Operating Profit
Operating ProfitCr
11
OPM
OPM%
10.110.4
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
01
PBT
PBTCr
11
Tax
TaxCr
00
PAT
PATCr
00
Growth
PAT Growth%
5.1
NPM
NPM%
4.84.4
EPS
EPS₹
1.91.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
22
Reserves
ReservesCr
77
Current Liabilities
Current LiabilitiesCr
21
Non Current Liabilities
Non Current LiabilitiesCr
01
Total Liabilities
Total LiabilitiesCr
1111
Current Assets
Current AssetsCr
77
Non Current Assets
Non Current AssetsCr
34
Total Assets
Total AssetsCr
1111
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
22
Reserves
ReservesCr
77
Current Liabilities
Current LiabilitiesCr
21
Non Current Liabilities
Non Current LiabilitiesCr
01
Total Liabilities
Total LiabilitiesCr
1111
Current Assets
Current AssetsCr
77
Non Current Assets
Non Current AssetsCr
34
Total Assets
Total AssetsCr
1111

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-1
Investing Cash Flow
Investing Cash FlowCr
-1-1
Financing Cash Flow
Financing Cash FlowCr
41
Net Cash Flow
Net Cash FlowCr
2-1
Free Cash Flow
Free Cash FlowCr
-2-2
CFO To PAT
CFO To PAT%
-222.6-191.1
CFO To EBITDA
CFO To EBITDA%
-105.6-80.3
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-1
Investing Cash Flow
Investing Cash FlowCr
-1-1
Financing Cash Flow
Financing Cash FlowCr
41
Net Cash Flow
Net Cash FlowCr
2-1
Free Cash Flow
Free Cash FlowCr
-2-2
CFO To PAT
CFO To PAT%
-222.6-191.1
CFO To EBITDA
CFO To EBITDA%
-105.6-80.3

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
988
Price To Earnings
Price To Earnings
23.319.119.1
Price To Sales
Price To Sales
1.10.80.8
Price To Book
Price To Book
1.00.90.9
EV To EBITDA
EV To EBITDA
7.36.56.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.471.571.5
OPM
OPM%
10.110.410.4
NPM
NPM%
4.84.44.4
ROCE
ROCE%
6.96.86.8
ROE
ROE%
4.54.54.5
ROA
ROA%
3.63.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
988
Price To Earnings
Price To Earnings
23.319.119.1
Price To Sales
Price To Sales
1.10.80.8
Price To Book
Price To Book
1.00.90.9
EV To EBITDA
EV To EBITDA
7.36.56.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.471.571.5
OPM
OPM%
10.110.410.4
NPM
NPM%
4.84.44.4
ROCE
ROCE%
6.96.86.8
ROE
ROE%
4.54.54.5
ROA
ROA%
3.63.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Clinitech Laboratory Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/azeeoaporfsyognyqntl7e6a.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/psrm1a9chfhzkpe47uh7ztbd.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/q6jtlpf2xi68019gq22gxbvc.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/hzoradlvx0w84p9nbhsi0dur.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/js8ivkghw97rhysw7bit1sz5.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/baxn24e9knt67l1h1w7mr4hu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies